These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 827618)

  • 21. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies.
    Magnuson BA; Burdock GA; Doull J; Kroes RM; Marsh GM; Pariza MW; Spencer PS; Waddell WJ; Walker R; Williams GM
    Crit Rev Toxicol; 2007; 37(8):629-727. PubMed ID: 17828671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspartame intolerance.
    Garriga MM; Metcalfe DD
    Ann Allergy; 1988 Dec; 61(6 Pt 2):63-9. PubMed ID: 3061324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspartame--a sweet surprise.
    Mazur RH
    J Toxicol Environ Health; 1976 Sep; 2(1):243-9. PubMed ID: 994241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of aspartame in beverages using an alcohol oxidase enzyme electrode.
    Smith VJ; Green RA; Hopkins TR
    J Assoc Off Anal Chem; 1989; 72(1):30-3. PubMed ID: 2654124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new application of molecularly imprinted materials.
    Ye L; Ramström O; Månsson MO; Mosbach K
    J Mol Recognit; 1998; 11(1-6):75-8. PubMed ID: 10076810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Racemization of aspartic acid and phenylalanine in the sweetener aspartame at 100 degrees C.
    Boehm MF; Bada JL
    Proc Natl Acad Sci U S A; 1984 Aug; 81(16):5263-6. PubMed ID: 6591191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma phenylalanine levels in phenylketonuric heterozygous and normal adults administered aspartame at 34 mg/kg body weight.
    Stegink LD; Koch R; Blaskovics ME; Filer LJ; Baker GL; McDonnell JE
    Toxicology; 1981; 20(1):81-90. PubMed ID: 7268794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitrosation of aspartic acid, aspartame, and glycine ethylester. Alkylation of 4-(p-nitrobenzyl)pyridine (NBP) in vitro and binding to DNA in the rat.
    Meier I; Shephard SE; Lutz WK
    Mutat Res; 1990 May; 238(3):193-201. PubMed ID: 2342512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal absorption of aspartame decomposition products in adult rats.
    Lipton WE; Li YN; Younoszai MK; Stegink LD
    Metabolism; 1991 Dec; 40(12):1337-45. PubMed ID: 1961131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The biological properties of aspartame. V. Effects on a variety of physiological parameters related to inflammation and metabolism.
    Aspinall RL; Saunders RN; Pautsch WF; Nutting EF
    J Environ Pathol Toxicol; 1980; 3(5-6):387-95. PubMed ID: 6108346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspartame administration to the infant monkey: hypothalamic morphology and plasma amino acid levels.
    Reynolds WA; Stegink LD; Filer LJ; Renn E
    Anat Rec; 1980 Sep; 198(1):73-85. PubMed ID: 7457932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of aspartame loading on plasma and erythrocyte free amino acid concentrations in one-year-old infants.
    Filer LJ; Baker GL; Stegink LD
    J Nutr; 1983 Aug; 113(8):1591-9. PubMed ID: 6135765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood methanol concentrations in normal adult subjects administered abuse doses of aspartame.
    Stegink LD; Brummel MC; McMartin K; Martin-Amat G; Filer LJ; Baker GL; Tephly TR
    J Toxicol Environ Health; 1981 Feb; 7(2):281-90. PubMed ID: 7230276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspartame: review of recent experimental and observational data.
    Janssen PJ; van der Heijden CA
    Toxicology; 1988 Jun; 50(1):1-26. PubMed ID: 3291200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute effects of aspartame on systolic blood pressure in spontaneously hypertensive rats.
    Kiritsy PJ; Maher TJ
    J Neural Transm; 1986; 66(2):121-8. PubMed ID: 3746286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspartame: clinical update.
    Potenza DP; el-Mallakh RS
    Conn Med; 1989 Jul; 53(7):395-400. PubMed ID: 2667892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma concentrations and pharmacokinetics of phenylalanine in rats and mice administered aspartame.
    Hjelle JJ; Dudley RE; Marietta MP; Sanders PG; Dickie BC; Brisson J; Kotsonis FN
    Pharmacology; 1992; 44(1):48-60. PubMed ID: 1553388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The debate over neurotransmitter interaction in aspartame usage.
    Choudhary AK; Lee YY
    J Clin Neurosci; 2018 Oct; 56():7-15. PubMed ID: 30318075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspartame. Review of safety issues. Council on Scientific Affairs.
    JAMA; 1985 Jul; 254(3):400-2. PubMed ID: 2861297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum methanol concentrations in rats and in men after a single dose of aspartame.
    Davoli E; Cappellini L; Airoldi L; Fanelli R
    Food Chem Toxicol; 1986 Mar; 24(3):187-9. PubMed ID: 3957170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.